Form 4: Soleno Therapeutics Exec Sells Shares for Tax Obligations
Insider Transaction Report
Patricia C. Hirano, SVP of Regulatory Affairs at Soleno Therapeutics, sold 904 shares of common stock to cover tax obligations from RSU vesting.
Summary
- Patricia C. Hirano, Senior Vice President of Regulatory Affairs at Soleno Therapeutics Inc. (SLNO), reported a transaction on December 15, 2025.
- The transaction involved the disposition of 904 shares of common stock at a price of $49.95 per share.
- This disposition was for tax withholding obligations in connection with the settlement of restricted stock units (RSUs) that vested on the same date.
- Following this transaction, Ms. Hirano beneficially owns 12,302 shares of Soleno Therapeutics common stock, which includes certain RSUs.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction for tax withholding purposes upon RSU vesting, which is generally considered a neutral event and does not reflect discretionary buying or selling.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine, non-discretionary transaction for tax purposes related to equity compensation.
Key Dates
| Date | Description |
|---|---|
| 12/15/2025 | Date of transaction for disposition of shares due to RSU vesting and tax withholding. |
| 12/17/2025 | Date the Form 4 was signed by the attorney-in-fact for the reporting person. |
Keywords
Soleno Therapeutics, SLNO, Form 4, Insider Transaction, Restricted Stock Units, Tax Withholding, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.